Buy Idea: ALPS Medical Breakthroughs ETF

Research Notes October 2025 > https://www.unum.capital/post/roct2025

Trade Local & Global Financial Markets with Unum Capital.

To get started, email tradingdesk@unum.co.za

The ALPS Medical Breakthroughs ETF (SBIO) provides exposure to small- and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the US Food and Drug Administration clinical trials. Constituents must have a market capitalization of no less than $200 million and no more than $5 billion.

Buy: $40.89 (or better/lower)

Stop-loss: $36.20

Target: $50.00, $54.00

Lester Davids

Senior Investment Analyst: Unum Capital